The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA.

"Declarations Ethics approval and consent to participateThe Ethics Committee of Ruijin Hospital affiliated with Shanghai Jiao Tong University approved the study. Informed consent was obtained from all individual participants included in the study. Consent for publicationConsent to publish has been obtained from all authors. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding This work was supported by grants from the National Natural Science Foundation of China (81470894, 81802316, 81871906, 82073326, 82173226, 82173219), Shanghai Rising-Star Program grant (19QA1405700), Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (RC20200037), Medical-Engineering Cross Foundation of Shanghai Jiao Tong University (ZH2018ZDA01), Shanghai Pilot Program for Basic Research-Shanghai Jiao Tong University (21TQ1400205), and Shanghai Collaborative Innovation Center for Translational Medicine (TM201903)."